nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Temsirolimus—kidney cancer	0.11	0.169	CbGbCtD
Oxymorphone—CYP3A4—Everolimus—kidney cancer	0.104	0.159	CbGbCtD
Oxymorphone—CYP3A4—Temsirolimus—kidney cancer	0.0702	0.108	CbGbCtD
Oxymorphone—CYP2D6—Pazopanib—kidney cancer	0.058	0.0889	CbGbCtD
Oxymorphone—CYP2D6—Erlotinib—kidney cancer	0.0414	0.0635	CbGbCtD
Oxymorphone—CYP3A4—Pazopanib—kidney cancer	0.0369	0.0565	CbGbCtD
Oxymorphone—CYP2D6—Sorafenib—kidney cancer	0.0336	0.0516	CbGbCtD
Oxymorphone—CYP2D6—Vinblastine—kidney cancer	0.0332	0.0509	CbGbCtD
Oxymorphone—CYP3A4—Erlotinib—kidney cancer	0.0263	0.0404	CbGbCtD
Oxymorphone—CYP3A4—Paclitaxel—kidney cancer	0.0241	0.0369	CbGbCtD
Oxymorphone—CYP3A4—Sorafenib—kidney cancer	0.0214	0.0328	CbGbCtD
Oxymorphone—CYP3A4—Vinblastine—kidney cancer	0.0211	0.0324	CbGbCtD
Oxymorphone—CYP3A4—Vincristine—kidney cancer	0.0208	0.0319	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—kidney cancer	0.0204	0.0313	CbGbCtD
Oxymorphone—CYP3A4—Sunitinib—kidney cancer	0.0173	0.0266	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—kidney cancer	0.013	0.0199	CbGbCtD
Oxymorphone—Hydromorphone—PTGS1—kidney cancer	0.000731	0.326	CrCbGaD
Oxymorphone—Naltrexone—ABCB1—kidney cancer	0.000491	0.219	CrCbGaD
Oxymorphone—Buprenorphine—ABCB1—kidney cancer	0.000361	0.161	CrCbGaD
Oxymorphone—Naloxone—ABCB1—kidney cancer	0.000358	0.16	CrCbGaD
Oxymorphone—Dizziness—Vinblastine—kidney cancer	0.000353	0.00102	CcSEcCtD
Oxymorphone—Dizziness—Everolimus—kidney cancer	0.000352	0.00102	CcSEcCtD
Oxymorphone—Abdominal pain—Sunitinib—kidney cancer	0.000351	0.00102	CcSEcCtD
Oxymorphone—Body temperature increased—Sunitinib—kidney cancer	0.000351	0.00102	CcSEcCtD
Oxymorphone—Diarrhoea—Erlotinib—kidney cancer	0.000351	0.00102	CcSEcCtD
Oxymorphone—Hypotension—Vincristine—kidney cancer	0.000351	0.00101	CcSEcCtD
Oxymorphone—Bradycardia—Capecitabine—kidney cancer	0.000351	0.00101	CcSEcCtD
Oxymorphone—Nervous system disorder—Gemcitabine—kidney cancer	0.000349	0.00101	CcSEcCtD
Oxymorphone—Feeling abnormal—Dactinomycin—kidney cancer	0.000346	0.001	CcSEcCtD
Oxymorphone—Skin disorder—Gemcitabine—kidney cancer	0.000346	0.001	CcSEcCtD
Oxymorphone—Vision blurred—Paclitaxel—kidney cancer	0.000345	0.000996	CcSEcCtD
Oxymorphone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000344	0.000996	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000344	0.000994	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—kidney cancer	0.000343	0.000993	CcSEcCtD
Oxymorphone—Urinary tract disorder—Capecitabine—kidney cancer	0.00034	0.000984	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—kidney cancer	0.00034	0.000984	CcSEcCtD
Oxymorphone—Hypersensitivity—Sorafenib—kidney cancer	0.00034	0.000983	CcSEcCtD
Oxymorphone—Insomnia—Vincristine—kidney cancer	0.00034	0.000982	CcSEcCtD
Oxymorphone—Anorexia—Gemcitabine—kidney cancer	0.00034	0.000982	CcSEcCtD
Oxymorphone—Vomiting—Vinblastine—kidney cancer	0.000339	0.000981	CcSEcCtD
Oxymorphone—Dizziness—Erlotinib—kidney cancer	0.000339	0.000981	CcSEcCtD
Oxymorphone—Vomiting—Everolimus—kidney cancer	0.000338	0.000978	CcSEcCtD
Oxymorphone—Urethral disorder—Capecitabine—kidney cancer	0.000338	0.000977	CcSEcCtD
Oxymorphone—Agitation—Paclitaxel—kidney cancer	0.000336	0.000971	CcSEcCtD
Oxymorphone—Dermatitis—Everolimus—kidney cancer	0.000335	0.000969	CcSEcCtD
Oxymorphone—Headache—Vinblastine—kidney cancer	0.000334	0.000967	CcSEcCtD
Oxymorphone—Headache—Everolimus—kidney cancer	0.000333	0.000963	CcSEcCtD
Oxymorphone—Hypotension—Gemcitabine—kidney cancer	0.000333	0.000963	CcSEcCtD
Oxymorphone—Body temperature increased—Dactinomycin—kidney cancer	0.000332	0.000961	CcSEcCtD
Oxymorphone—Abdominal pain—Dactinomycin—kidney cancer	0.000332	0.000961	CcSEcCtD
Oxymorphone—Visual impairment—Capecitabine—kidney cancer	0.000332	0.00096	CcSEcCtD
Oxymorphone—Asthenia—Sorafenib—kidney cancer	0.000331	0.000958	CcSEcCtD
Oxymorphone—Vertigo—Paclitaxel—kidney cancer	0.000328	0.00095	CcSEcCtD
Oxymorphone—Syncope—Paclitaxel—kidney cancer	0.000328	0.000948	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—kidney cancer	0.000328	0.000948	CcSEcCtD
Oxymorphone—Hypersensitivity—Sunitinib—kidney cancer	0.000327	0.000946	CcSEcCtD
Oxymorphone—Decreased appetite—Vincristine—kidney cancer	0.000327	0.000944	CcSEcCtD
Oxymorphone—Pruritus—Sorafenib—kidney cancer	0.000327	0.000944	CcSEcCtD
Oxymorphone—Vomiting—Erlotinib—kidney cancer	0.000326	0.000943	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000324	0.000938	CcSEcCtD
Oxymorphone—Fatigue—Vincristine—kidney cancer	0.000324	0.000936	CcSEcCtD
Oxymorphone—Dermatitis—Erlotinib—kidney cancer	0.000323	0.000935	CcSEcCtD
Oxymorphone—Palpitations—Paclitaxel—kidney cancer	0.000323	0.000934	CcSEcCtD
Oxymorphone—Insomnia—Gemcitabine—kidney cancer	0.000322	0.000932	CcSEcCtD
Oxymorphone—Eye disorder—Capecitabine—kidney cancer	0.000322	0.000931	CcSEcCtD
Oxymorphone—Headache—Erlotinib—kidney cancer	0.000321	0.000929	CcSEcCtD
Oxymorphone—Loss of consciousness—Paclitaxel—kidney cancer	0.000321	0.000929	CcSEcCtD
Oxymorphone—Pain—Vincristine—kidney cancer	0.000321	0.000929	CcSEcCtD
Oxymorphone—Constipation—Vincristine—kidney cancer	0.000321	0.000929	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—kidney cancer	0.000321	0.000929	CcSEcCtD
Oxymorphone—Flushing—Capecitabine—kidney cancer	0.00032	0.000925	CcSEcCtD
Oxymorphone—Cardiac disorder—Capecitabine—kidney cancer	0.00032	0.000925	CcSEcCtD
Oxymorphone—Asthenia—Sunitinib—kidney cancer	0.000319	0.000921	CcSEcCtD
Oxymorphone—Dyspnoea—Gemcitabine—kidney cancer	0.000318	0.000919	CcSEcCtD
Oxymorphone—Nausea—Vinblastine—kidney cancer	0.000317	0.000917	CcSEcCtD
Oxymorphone—Somnolence—Gemcitabine—kidney cancer	0.000317	0.000916	CcSEcCtD
Oxymorphone—Convulsion—Paclitaxel—kidney cancer	0.000317	0.000916	CcSEcCtD
Oxymorphone—Nausea—Everolimus—kidney cancer	0.000316	0.000913	CcSEcCtD
Oxymorphone—Diarrhoea—Sorafenib—kidney cancer	0.000316	0.000913	CcSEcCtD
Oxymorphone—Hypertension—Paclitaxel—kidney cancer	0.000316	0.000913	CcSEcCtD
Oxymorphone—Pruritus—Sunitinib—kidney cancer	0.000314	0.000909	CcSEcCtD
Oxymorphone—Angiopathy—Capecitabine—kidney cancer	0.000313	0.000904	CcSEcCtD
Oxymorphone—Immune system disorder—Capecitabine—kidney cancer	0.000311	0.0009	CcSEcCtD
Oxymorphone—Chest pain—Paclitaxel—kidney cancer	0.000311	0.0009	CcSEcCtD
Oxymorphone—Mediastinal disorder—Capecitabine—kidney cancer	0.000311	0.000898	CcSEcCtD
Oxymorphone—Anxiety—Paclitaxel—kidney cancer	0.00031	0.000897	CcSEcCtD
Oxymorphone—Decreased appetite—Gemcitabine—kidney cancer	0.00031	0.000896	CcSEcCtD
Oxymorphone—Hypersensitivity—Dactinomycin—kidney cancer	0.00031	0.000896	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000309	0.000894	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000308	0.00089	CcSEcCtD
Oxymorphone—Fatigue—Gemcitabine—kidney cancer	0.000307	0.000888	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Vincristine—kidney cancer	0.000307	0.000888	CcSEcCtD
Oxymorphone—Dizziness—Sorafenib—kidney cancer	0.000305	0.000883	CcSEcCtD
Oxymorphone—Pain—Gemcitabine—kidney cancer	0.000305	0.000881	CcSEcCtD
Oxymorphone—Constipation—Gemcitabine—kidney cancer	0.000305	0.000881	CcSEcCtD
Oxymorphone—Nausea—Erlotinib—kidney cancer	0.000305	0.000881	CcSEcCtD
Oxymorphone—Dry mouth—Paclitaxel—kidney cancer	0.000304	0.00088	CcSEcCtD
Oxymorphone—Diarrhoea—Sunitinib—kidney cancer	0.000304	0.000879	CcSEcCtD
Oxymorphone—Morphine—ABCB1—kidney cancer	0.000302	0.135	CrCbGaD
Oxymorphone—Mental disorder—Capecitabine—kidney cancer	0.000302	0.000873	CcSEcCtD
Oxymorphone—Asthenia—Dactinomycin—kidney cancer	0.000302	0.000872	CcSEcCtD
Oxymorphone—Confusional state—Paclitaxel—kidney cancer	0.000301	0.00087	CcSEcCtD
Oxymorphone—Malnutrition—Capecitabine—kidney cancer	0.0003	0.000868	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—kidney cancer	0.000299	0.000864	CcSEcCtD
Oxymorphone—Oedema—Paclitaxel—kidney cancer	0.000298	0.000863	CcSEcCtD
Oxymorphone—Abdominal pain—Vincristine—kidney cancer	0.000297	0.000859	CcSEcCtD
Oxymorphone—Body temperature increased—Vincristine—kidney cancer	0.000297	0.000859	CcSEcCtD
Oxymorphone—Flatulence—Capecitabine—kidney cancer	0.000296	0.000855	CcSEcCtD
Oxymorphone—Dizziness—Sunitinib—kidney cancer	0.000294	0.000849	CcSEcCtD
Oxymorphone—Feeling abnormal—Gemcitabine—kidney cancer	0.000294	0.000849	CcSEcCtD
Oxymorphone—Shock—Paclitaxel—kidney cancer	0.000294	0.000849	CcSEcCtD
Oxymorphone—Vomiting—Sorafenib—kidney cancer	0.000293	0.000849	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000293	0.000848	CcSEcCtD
Oxymorphone—Nervous system disorder—Paclitaxel—kidney cancer	0.000293	0.000846	CcSEcCtD
Oxymorphone—Tachycardia—Paclitaxel—kidney cancer	0.000291	0.000842	CcSEcCtD
Oxymorphone—Dermatitis—Sorafenib—kidney cancer	0.000291	0.000841	CcSEcCtD
Oxymorphone—Skin disorder—Paclitaxel—kidney cancer	0.00029	0.000838	CcSEcCtD
Oxymorphone—Headache—Sorafenib—kidney cancer	0.000289	0.000836	CcSEcCtD
Oxymorphone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000288	0.000834	CcSEcCtD
Oxymorphone—Diarrhoea—Dactinomycin—kidney cancer	0.000288	0.000832	CcSEcCtD
Oxymorphone—Anorexia—Paclitaxel—kidney cancer	0.000284	0.000822	CcSEcCtD
Oxymorphone—Vision blurred—Capecitabine—kidney cancer	0.000283	0.000818	CcSEcCtD
Oxymorphone—Vomiting—Sunitinib—kidney cancer	0.000282	0.000817	CcSEcCtD
Oxymorphone—Body temperature increased—Gemcitabine—kidney cancer	0.000282	0.000815	CcSEcCtD
Oxymorphone—Dermatitis—Sunitinib—kidney cancer	0.00028	0.000809	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—kidney cancer	0.000279	0.000808	CcSEcCtD
Oxymorphone—Hypotension—Paclitaxel—kidney cancer	0.000279	0.000806	CcSEcCtD
Oxymorphone—Headache—Sunitinib—kidney cancer	0.000278	0.000805	CcSEcCtD
Oxymorphone—Hypersensitivity—Vincristine—kidney cancer	0.000277	0.0008	CcSEcCtD
Oxymorphone—Nausea—Sorafenib—kidney cancer	0.000274	0.000793	CcSEcCtD
Oxymorphone—Insomnia—Paclitaxel—kidney cancer	0.00027	0.00078	CcSEcCtD
Oxymorphone—Vertigo—Capecitabine—kidney cancer	0.00027	0.000779	CcSEcCtD
Oxymorphone—Asthenia—Vincristine—kidney cancer	0.00027	0.000779	CcSEcCtD
Oxymorphone—Syncope—Capecitabine—kidney cancer	0.000269	0.000778	CcSEcCtD
Oxymorphone—Vomiting—Dactinomycin—kidney cancer	0.000267	0.000773	CcSEcCtD
Oxymorphone—Dyspnoea—Paclitaxel—kidney cancer	0.000266	0.000769	CcSEcCtD
Oxymorphone—Somnolence—Paclitaxel—kidney cancer	0.000265	0.000767	CcSEcCtD
Oxymorphone—Palpitations—Capecitabine—kidney cancer	0.000265	0.000767	CcSEcCtD
Oxymorphone—Nausea—Sunitinib—kidney cancer	0.000264	0.000763	CcSEcCtD
Oxymorphone—Loss of consciousness—Capecitabine—kidney cancer	0.000264	0.000762	CcSEcCtD
Oxymorphone—Dyspepsia—Paclitaxel—kidney cancer	0.000263	0.000759	CcSEcCtD
Oxymorphone—Decreased appetite—Paclitaxel—kidney cancer	0.000259	0.00075	CcSEcCtD
Oxymorphone—Hypertension—Capecitabine—kidney cancer	0.000259	0.000749	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000258	0.000745	CcSEcCtD
Oxymorphone—Fatigue—Paclitaxel—kidney cancer	0.000257	0.000744	CcSEcCtD
Oxymorphone—Diarrhoea—Vincristine—kidney cancer	0.000257	0.000743	CcSEcCtD
Oxymorphone—Asthenia—Gemcitabine—kidney cancer	0.000256	0.000739	CcSEcCtD
Oxymorphone—Chest pain—Capecitabine—kidney cancer	0.000255	0.000739	CcSEcCtD
Oxymorphone—Constipation—Paclitaxel—kidney cancer	0.000255	0.000738	CcSEcCtD
Oxymorphone—Pain—Paclitaxel—kidney cancer	0.000255	0.000738	CcSEcCtD
Oxymorphone—Anxiety—Capecitabine—kidney cancer	0.000255	0.000736	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000254	0.000733	CcSEcCtD
Oxymorphone—Pruritus—Gemcitabine—kidney cancer	0.000252	0.000729	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—kidney cancer	0.000251	0.000726	CcSEcCtD
Oxymorphone—Dry mouth—Capecitabine—kidney cancer	0.00025	0.000722	CcSEcCtD
Oxymorphone—Nausea—Dactinomycin—kidney cancer	0.00025	0.000722	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—kidney cancer	0.000249	0.00072	CcSEcCtD
Oxymorphone—Dizziness—Vincristine—kidney cancer	0.000248	0.000718	CcSEcCtD
Oxymorphone—Confusional state—Capecitabine—kidney cancer	0.000247	0.000714	CcSEcCtD
Oxymorphone—Feeling abnormal—Paclitaxel—kidney cancer	0.000246	0.000711	CcSEcCtD
Oxymorphone—Oedema—Capecitabine—kidney cancer	0.000245	0.000708	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000244	0.000705	CcSEcCtD
Oxymorphone—Diarrhoea—Gemcitabine—kidney cancer	0.000244	0.000705	CcSEcCtD
Oxymorphone—Shock—Capecitabine—kidney cancer	0.000241	0.000697	CcSEcCtD
Oxymorphone—Nervous system disorder—Capecitabine—kidney cancer	0.00024	0.000694	CcSEcCtD
Oxymorphone—Tachycardia—Capecitabine—kidney cancer	0.000239	0.000691	CcSEcCtD
Oxymorphone—Vomiting—Vincristine—kidney cancer	0.000239	0.000691	CcSEcCtD
Oxymorphone—Skin disorder—Capecitabine—kidney cancer	0.000238	0.000688	CcSEcCtD
Oxymorphone—Urticaria—Paclitaxel—kidney cancer	0.000237	0.000685	CcSEcCtD
Oxymorphone—Hyperhidrosis—Capecitabine—kidney cancer	0.000237	0.000684	CcSEcCtD
Oxymorphone—Dermatitis—Vincristine—kidney cancer	0.000237	0.000684	CcSEcCtD
Oxymorphone—Abdominal pain—Paclitaxel—kidney cancer	0.000236	0.000682	CcSEcCtD
Oxymorphone—Body temperature increased—Paclitaxel—kidney cancer	0.000236	0.000682	CcSEcCtD
Oxymorphone—Headache—Vincristine—kidney cancer	0.000235	0.00068	CcSEcCtD
Oxymorphone—Anorexia—Capecitabine—kidney cancer	0.000233	0.000675	CcSEcCtD
Oxymorphone—Hypotension—Capecitabine—kidney cancer	0.000229	0.000662	CcSEcCtD
Oxymorphone—Vomiting—Gemcitabine—kidney cancer	0.000227	0.000655	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—kidney cancer	0.000226	0.000654	CcSEcCtD
Oxymorphone—Dermatitis—Gemcitabine—kidney cancer	0.000224	0.000649	CcSEcCtD
Oxymorphone—Headache—Gemcitabine—kidney cancer	0.000223	0.000646	CcSEcCtD
Oxymorphone—Nausea—Vincristine—kidney cancer	0.000223	0.000645	CcSEcCtD
Oxymorphone—Insomnia—Capecitabine—kidney cancer	0.000221	0.00064	CcSEcCtD
Oxymorphone—Hypersensitivity—Paclitaxel—kidney cancer	0.00022	0.000636	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—kidney cancer	0.000219	0.000634	CcSEcCtD
Oxymorphone—Dyspnoea—Capecitabine—kidney cancer	0.000218	0.000631	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—kidney cancer	0.000218	0.00063	CcSEcCtD
Oxymorphone—Dyspepsia—Capecitabine—kidney cancer	0.000216	0.000623	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—kidney cancer	0.000214	0.000619	CcSEcCtD
Oxymorphone—Asthenia—Paclitaxel—kidney cancer	0.000214	0.000619	CcSEcCtD
Oxymorphone—Decreased appetite—Capecitabine—kidney cancer	0.000213	0.000615	CcSEcCtD
Oxymorphone—Nausea—Gemcitabine—kidney cancer	0.000212	0.000612	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000211	0.000611	CcSEcCtD
Oxymorphone—Fatigue—Capecitabine—kidney cancer	0.000211	0.00061	CcSEcCtD
Oxymorphone—Pruritus—Paclitaxel—kidney cancer	0.000211	0.00061	CcSEcCtD
Oxymorphone—Pain—Capecitabine—kidney cancer	0.000209	0.000605	CcSEcCtD
Oxymorphone—Constipation—Capecitabine—kidney cancer	0.000209	0.000605	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—kidney cancer	0.000208	0.0006	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—kidney cancer	0.000206	0.000596	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—kidney cancer	0.000206	0.000596	CcSEcCtD
Oxymorphone—Diarrhoea—Paclitaxel—kidney cancer	0.000204	0.00059	CcSEcCtD
Oxymorphone—Feeling abnormal—Capecitabine—kidney cancer	0.000202	0.000583	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—kidney cancer	0.000202	0.000583	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—kidney cancer	0.000201	0.00058	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Capecitabine—kidney cancer	0.0002	0.000579	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—kidney cancer	0.0002	0.000579	CcSEcCtD
Oxymorphone—Dizziness—Paclitaxel—kidney cancer	0.000197	0.000571	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—kidney cancer	0.000195	0.000563	CcSEcCtD
Oxymorphone—Urticaria—Capecitabine—kidney cancer	0.000194	0.000562	CcSEcCtD
Oxymorphone—Abdominal pain—Capecitabine—kidney cancer	0.000194	0.00056	CcSEcCtD
Oxymorphone—Body temperature increased—Capecitabine—kidney cancer	0.000194	0.00056	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—kidney cancer	0.000193	0.000559	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—kidney cancer	0.000191	0.000551	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—kidney cancer	0.00019	0.000549	CcSEcCtD
Oxymorphone—Vomiting—Paclitaxel—kidney cancer	0.00019	0.000549	CcSEcCtD
Oxymorphone—Dermatitis—Paclitaxel—kidney cancer	0.000188	0.000543	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—kidney cancer	0.000188	0.000543	CcSEcCtD
Oxymorphone—Headache—Paclitaxel—kidney cancer	0.000187	0.00054	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—kidney cancer	0.000182	0.000527	CcSEcCtD
Oxymorphone—Hypersensitivity—Capecitabine—kidney cancer	0.00018	0.000522	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—kidney cancer	0.000178	0.000514	CcSEcCtD
Oxymorphone—Nausea—Paclitaxel—kidney cancer	0.000177	0.000512	CcSEcCtD
Oxymorphone—Asthenia—Capecitabine—kidney cancer	0.000176	0.000508	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—kidney cancer	0.000174	0.000502	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—kidney cancer	0.000173	0.000501	CcSEcCtD
Oxymorphone—Pruritus—Capecitabine—kidney cancer	0.000173	0.000501	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—kidney cancer	0.000171	0.000494	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—kidney cancer	0.00017	0.000491	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—kidney cancer	0.000168	0.000484	CcSEcCtD
Oxymorphone—Diarrhoea—Capecitabine—kidney cancer	0.000168	0.000484	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—kidney cancer	0.000167	0.000483	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—kidney cancer	0.000165	0.000476	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—kidney cancer	0.000164	0.000474	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000163	0.000473	CcSEcCtD
Oxymorphone—Dizziness—Capecitabine—kidney cancer	0.000162	0.000468	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—kidney cancer	0.000161	0.000466	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—kidney cancer	0.000159	0.00046	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—kidney cancer	0.000158	0.000456	CcSEcCtD
Oxymorphone—Vomiting—Capecitabine—kidney cancer	0.000156	0.00045	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—kidney cancer	0.000155	0.000449	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—kidney cancer	0.000155	0.000448	CcSEcCtD
Oxymorphone—Dermatitis—Capecitabine—kidney cancer	0.000154	0.000446	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—kidney cancer	0.000154	0.000445	CcSEcCtD
Oxymorphone—Headache—Capecitabine—kidney cancer	0.000153	0.000444	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—kidney cancer	0.000153	0.000443	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000153	0.000441	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—kidney cancer	0.00015	0.000435	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—kidney cancer	0.000147	0.000426	CcSEcCtD
Oxymorphone—Nausea—Capecitabine—kidney cancer	0.000145	0.000421	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—kidney cancer	0.000143	0.000413	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—kidney cancer	0.000141	0.000407	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—kidney cancer	0.00014	0.000406	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—kidney cancer	0.000139	0.000402	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—kidney cancer	0.000137	0.000397	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000136	0.000394	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—kidney cancer	0.000136	0.000393	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—kidney cancer	0.000135	0.00039	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—kidney cancer	0.000135	0.00039	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—kidney cancer	0.00013	0.000376	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000129	0.000373	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—kidney cancer	0.000125	0.000363	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—kidney cancer	0.000125	0.000361	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—kidney cancer	0.000125	0.000361	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—kidney cancer	0.000116	0.000336	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—kidney cancer	0.000113	0.000327	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—kidney cancer	0.000112	0.000323	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—kidney cancer	0.000108	0.000312	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—kidney cancer	0.000104	0.000302	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—kidney cancer	0.0001	0.00029	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—kidney cancer	9.94e-05	0.000287	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—kidney cancer	9.89e-05	0.000286	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—kidney cancer	9.37e-05	0.000271	CcSEcCtD
